94 related articles for article (PubMed ID: 21656517)
1. Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease.
Suzuki T; Toyohara T; Akiyama Y; Takeuchi Y; Mishima E; Suzuki C; Ito S; Soga T; Abe T
J Pharm Sci; 2011 Sep; 100(9):3696-707. PubMed ID: 21656517
[TBL] [Abstract][Full Text] [Related]
2. The kidney and uremic toxin removal: glomerulus or tubule?
Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
[TBL] [Abstract][Full Text] [Related]
3. SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
Toyohara T; Suzuki T; Morimoto R; Akiyama Y; Souma T; Shiwaku HO; Takeuchi Y; Mishima E; Abe M; Tanemoto M; Masuda S; Kawano H; Maemura K; Nakayama M; Sato H; Mikkaichi T; Yamaguchi H; Fukui S; Fukumoto Y; Shimokawa H; Inui K; Terasaki T; Goto J; Ito S; Hishinuma T; Rubera I; Tauc M; Fujii-Kuriyama Y; Yabuuchi H; Moriyama Y; Soga T; Abe T
J Am Soc Nephrol; 2009 Dec; 20(12):2546-55. PubMed ID: 19875811
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.
Akiyama Y; Kikuchi K; Saigusa D; Suzuki T; Takeuchi Y; Mishima E; Yamamoto Y; Ishida A; Sugawara D; Jinno D; Shima H; Toyohara T; Suzuki C; Souma T; Moriguchi T; Tomioka Y; Ito S; Abe T
PLoS One; 2013; 8(7):e66518. PubMed ID: 23874392
[TBL] [Abstract][Full Text] [Related]
5. Roles of organic anion transporters in the progression of chronic renal failure.
Enomoto A; Niwa T
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
[TBL] [Abstract][Full Text] [Related]
6. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.
Miyamoto Y; Watanabe H; Noguchi T; Kotani S; Nakajima M; Kadowaki D; Otagiri M; Maruyama T
Nephrol Dial Transplant; 2011 Aug; 26(8):2498-502. PubMed ID: 21303967
[TBL] [Abstract][Full Text] [Related]
7. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
8. Uremic Toxins in Organ Crosstalk.
Lowenstein J; Nigam SK
Front Med (Lausanne); 2021; 8():592602. PubMed ID: 33937275
[TBL] [Abstract][Full Text] [Related]
9. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
Aoyama I; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
[TBL] [Abstract][Full Text] [Related]
11. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
[TBL] [Abstract][Full Text] [Related]
12. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats.
Deguchi T; Takemoto M; Uehara N; Lindup WE; Suenaga A; Otagiri M
J Pharmacol Exp Ther; 2005 Aug; 314(2):932-8. PubMed ID: 15879000
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression, and ontogeny of mouse organic anion-transporting polypeptide-5, a kidney-specific organic anion transporter.
Choudhuri S; Ogura K; Klaassen CD
Biochem Biophys Res Commun; 2001 Jan; 280(1):92-8. PubMed ID: 11162483
[TBL] [Abstract][Full Text] [Related]
15. The influence of chronic renal failure on drug metabolism and transport.
Dreisbach AW
Clin Pharmacol Ther; 2009 Nov; 86(5):553-6. PubMed ID: 19776735
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
[TBL] [Abstract][Full Text] [Related]
17. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin.
Fischer WJ; Altheimer S; Cattori V; Meier PJ; Dietrich DR; Hagenbuch B
Toxicol Appl Pharmacol; 2005 Mar; 203(3):257-63. PubMed ID: 15737679
[TBL] [Abstract][Full Text] [Related]
18. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.
Nigam SK; Bush KT; Bhatnagar V
Nat Clin Pract Nephrol; 2007 Aug; 3(8):443-8. PubMed ID: 17653123
[TBL] [Abstract][Full Text] [Related]
19. Functions of OATP1A and 1B transporters in vivo: insights from mouse models.
Iusuf D; van de Steeg E; Schinkel AH
Trends Pharmacol Sci; 2012 Feb; 33(2):100-8. PubMed ID: 22130008
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications.
Saito H
Pharmacol Ther; 2010 Jan; 125(1):79-91. PubMed ID: 19837111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
